SEC 13F Intelligence

Meeder Asset Management Inc / ABBV

Meeder Asset Management Inc’s Abbvie Inc Position

Does Meeder Asset Management Inc own Abbvie Inc (ABBV)? Yes79.6K shares worth $17M (+0.99% of its 13F portfolio) as of Q1 2026, up from 70.0K shares the prior filed quarter.

Position Value
$17M
Q1 2026
Shares
79.6K
% of Portfolio
+0.99%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $4MQ2 ’19: $4MQ3 ’19: $5MQ4 ’19: $9MQ4 ’19Q1 ’20: $8MQ2 ’20: $12MQ3 ’20: $11MQ4 ’20: $2MQ4 ’20Q1 ’21: $13MQ2 ’21: $14MQ3 ’21: $14MQ1 ’22: $22MQ1 ’22Q2 ’22: $17MQ3 ’22: $15MQ4 ’22: $9MQ1 ’23: $14MQ1 ’23Q2 ’23: $12MQ3 ’23: $475,650Q4 ’23: $22MQ1 ’24: $5MQ1 ’24Q2 ’24: $19MQ3 ’24: $36MQ4 ’24: $2MQ1 ’25: $11MQ1 ’25Q2 ’25: $15MQ3 ’25: $13MQ4 ’25: $16MQ1 ’26: $17MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202679.6K$17M+0.99%
Q4 202570.0K$16M+0.86%
Q3 202554.5K$13M+0.72%
Q2 202579.5K$15M+0.91%
Q1 202550.9K$11M+0.72%
Q4 202411.4K$2M+0.14%
Q3 2024182.2K$36M+2.40%
Q2 2024112.6K$19M+1.35%
Q1 202426.7K$5M+0.31%
Q4 2023142.5K$22M+1.72%
Q3 20233.2K$475,650+0.04%
Q2 202390.8K$12M+0.89%
Q1 202389.5K$14M+1.14%
Q4 202255.6K$9M+0.79%
Q3 2022111.0K$15M+0.86%
Q2 2022110.8K$17M+0.98%
Q1 2022134.5K$22M+1.06%
Q3 2021127.2K$14M+0.72%
Q2 2021127.9K$14M+0.67%
Q1 2021124.5K$13M+0.69%
Q4 202017.4K$2M+0.41%
Q3 2020122.5K$11M+0.69%
Q2 2020121.8K$12M+0.78%
Q1 202099.9K$8M+0.59%
Q4 201997.0K$9M+0.52%
Q3 201970.5K$5M+0.36%
Q2 201960.0K$4M+0.30%
Q1 201947.9K$4M+0.30%
Q4 201843.1K$4M+0.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meeder Asset Management Inc’s full portfolio or all institutional holders of ABBV.